Keyword: Xellia Pharmaceuticals


FDA cuts Xellia some slack on consent decree for closed plant

The notorious ex-Boehringer Ingelheim plant in Bedford, OH, is still governed by a court-ordered consent decree ordering improvements to be made before it is serviceable again. But Denmark’s Xellia, which bought the plant last year, says the FDA is cutting it some slack on the provisions so it can ready the facility for manufacturing next year.